XML 413 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss, Net of Tax
Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2020   225.5      
Beginning Balance at Dec. 31, 2020 $ 3,583 $ 6,314 $ 1,042 $ (3,861) $ 88
Increase (Decrease) in Shareholders' Equity          
Net income 1,308   1,255   53
Shares issued — employee stock compensation plans (in shares)   1.7      
Shares issued — employee stock compensation plans (130) $ (129) (1)    
Shares repurchased (in shares)   (12.4)      
Shares repurchased (3,543)   (3,543)    
Share-based compensation expense 449 $ 449      
Dividends to shareholders (447)   (447)    
Net change in fair value of financial instruments 1     1  
Net foreign currency translation adjustments (289)     (288) (1)
Net postretirement benefit obligation 277     277  
Net purchases of shares from noncontrolling interests (13) $ (8)     (5)
Dividends paid to noncontrolling interests on subsidiary common stock (38)       (38)
Ending Balance (in shares) at Dec. 31, 2021   214.8      
Ending Balance at Dec. 31, 2021 1,158 $ 6,626 (1,694) (3,871) 97
Increase (Decrease) in Shareholders' Equity          
Net income 2,646   2,589   57
Shares issued — employee stock compensation plans (in shares)   1.7      
Shares issued — employee stock compensation plans (157) $ (156) (1)    
Shares repurchased (in shares)   (11.1)      
Shares repurchased (3,203)   (3,203)    
Share-based compensation expense 397 $ 397      
Dividends to shareholders (463)   (463)    
Net change in fair value of financial instruments (13)     (13)  
Net foreign currency translation adjustments (528)     (528)  
Net postretirement benefit obligation (211)     (211)  
Net purchases of shares from noncontrolling interests (2) $ (1)     (1)
Dividends paid to noncontrolling interests on subsidiary common stock $ (53)       (53)
Ending Balance (in shares) at Dec. 31, 2022 205.4 205.4      
Ending Balance at Dec. 31, 2022 $ (429) $ 6,866 (2,772) (4,623) 100
Increase (Decrease) in Shareholders' Equity          
Net income 2,628   2,564   64
Shares issued — employee stock compensation plans (in shares)   1.6      
Shares issued — employee stock compensation plans (169) $ (168) (1)    
Shares repurchased (in shares)   (8.4)      
Shares repurchased (2,700)   (2,700)    
Share-based compensation expense 438 $ 438      
Dividends to shareholders (490)   (490)    
Net change in fair value of financial instruments 13     13  
Net foreign currency translation adjustments 276     277 (1)
Net postretirement benefit obligation (40)     (40)  
Net purchases of shares from noncontrolling interests (213) $ (190)     (23)
Dividends paid to noncontrolling interests on subsidiary common stock $ (56)       (56)
Ending Balance (in shares) at Dec. 31, 2023 198.6 198.6      
Ending Balance at Dec. 31, 2023 $ (742) $ 6,946 $ (3,399) $ (4,373) $ 84